Pharmafile Logo
Pharmafocus logo
Advanced Search

results

Showing 15 posts of 36 posts found.

sanofi_hq__boetie_hall

Sanofi confirm 2016 outlook with Q1 results, EPS rises 5.3%

April 29, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2016, Q1, Sanofi, earnings, outlook, results

Sanofi (EPA: SAN) has confirmed its outlook for 2016 with the publication of their first quarter results, with earnings per …

News
astrazeneca_sign_sky

AstraZeneca Q1 earnings down 12%; maintains FY view

April 29, 2016
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results

UK drugmaker AstraZeneca (LSE: AZN) on Friday reported a 12% drop in first-quarter earnings and said it plans to streamline …

News
sobi

Sobi profits rise as it rolls out haemophilia drug in Europe

April 28, 2016
Financial, Q1, earnings, results, revenue, sobi

Swedish Orphan Biovitrum (Sobi) (STO: SOBI) nearly doubled its first-quarter profit driven by immediate reimbursements from Germany. The company reported …

News
gsk-house-location-building

GlaxoSmithKline Q1 earnings up 14% on new product sales

April 27, 2016
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Q1, earnings, results, revenue, sales

GlaxoSmithKline (LSE: GSK) reported a 14% rise in first-quarter earnings driven by demand for new drugs. The UK drug firm …

News
baxter

Baxter hikes 2016 earnings view driven by strong Q1 results

April 27, 2016
Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue

Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …

News
credit_bayerag

Bayer’s earnings beat estimates as blockbusters shine

April 26, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Eylea, Q1, Xarelto, blockbusters, growth, results, sales

Bayer (FWB: BAYN) has reported a 15.7% rise in underlying core earnings for the first quarter of 2016, with prescription …

News
biogen_logo

Biogen Q1 profits rise boosted by Tecfidera sales

April 22, 2016
Medical Communications, Sales and Marketing Biogen, Q1, biotech, earnings, results, tecfidera

Shares in Biogen (Nasdaq: BIIB) climbed to close up over 5% Thursday after the company reported 18% rise in first-quarter …

News
novartis_side_building

Novartis Q1 earnings drop as cancer drug sales falter

April 21, 2016
Business Services, Sales and Marketing Financial, Novartis, earnings, first quarter, results

Swiss drugmaker Novartis (SIX: NOVN) on Thursday reported a 13% drop in net income for the first quarter on the …

News
bi_microparts_image

Boehringer Ingelheim posts 11% rise in FY15 sales boosted by diabetes business

April 20, 2016
Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, FY, earnings, forecasts, outlook, results

Boehringer Ingelheim reported 11% jump in sales for 2015 driven by its diabetes business and said for 2016 it sees …

News
jj_sign_on_wall

J&J raises FY outlook, Q1 beats estimates

April 20, 2016
Business Services, Research and Development, Sales and Marketing Financial, Johnson & Johnson, Q1, earnings, results, revenue, sales

Healthcare giant Johnson & Johnson (NYSE: JNJ) raised its full-year outlook and posted first-quarter earnings ahead of estimates despite currency headwinds. …

News
roche_dark_0

Roche reports 5% rise in Q1 sales boosted by cancer drugs

April 19, 2016
Manufacturing and Production, Sales and Marketing Q1, Roche, earnings, oncology drugs, results

Oncology drug maker Roche (VTX: ROG) on Tuesday reported 5% increase in first-quarter sales driven by cancer drugs. The company …

News
valeant_logo

Valeant cuts 2016 sales, earnings outlook; shares plunge over 47%

March 15, 2016
Business Services, Manufacturing and Production, Sales and Marketing Valeant Pharma, fourth quarter, full year, results

Valeant Pharmaceuticals Inc (NYSE: VRX) cut its outlook for the first-quarter of 2016 and posted a loss for the final …

News

Boehringer assures future growth following sales drop

April 23, 2015
Sales and Marketing Boehringer, COPD, Glyxambi, Striverdi Respimat, empagliflozin, empagliflozin/linagliptin, financials, full year, jardiance, nintedanib, ofev, olodaterol, results

Boehringer says it is positioned for future growth in the wake of filing a decline in profit for 2014 and …

News
Merck image

Merck: ‘2014 revenues will be down’

February 7, 2014
Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results

Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …

News
Astrazeneca image

AstraZeneca battling ‘headwinds’

February 7, 2014
Sales and Marketing AstraZeneca, Soriot, farxiga, q4, results, xigduo

AstraZeneca is to shed another 550 jobs as its latest corporate restructure takes shape, bringing to 5,600 the number of …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026